Article Details

Morgan Stanley Reaffirms Underweight Rating for Synthomer (LON:SYNT) | MarketBeat

Retrieved on: 2022-01-26 19:39:53

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Reaffirms Underweight Rating for Synthomer (LON:SYNT) | MarketBeat. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/lon-synt-a-buy-or-sell-right-now-2022-01-2-3/

Excerpt

Morgan Stanley reissued an "underweight" rating and set a GBX 400 ($5.40) target price on shares of Synthomer in a research note on Wednesday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up